Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 6 publications
Understanding the role of SGLT2 inhibitors in glycogen storage disease type Ib: the experience of one UK centre.
Journal: Orphanet journal of rare diseases
Published: January 14, 2022
The natural history of glycogen storage disease type Ib in England: A multisite survey.
Journal: JIMD reports
Published: October 20, 2020
Long-Term Continuous Suppression With Once-Yearly Histrelin Subcutaneous Implants for the Treatment of Central Precocious Puberty: A Final Report of a Phase 3 Multicenter Trial.
Journal: The Journal of clinical endocrinology and metabolism
Published: March 25, 2015
BIRD'S-EYE VIEW OF GnRH ANALOG USE IN A PEDIATRIC ENDOCRINOLOGY REFERRAL CENTER.
Journal: Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists
Published: February 11, 2015
A single histrelin implant is effective for 2 years for treatment of central precocious puberty.
Journal: The Journal of pediatrics
Published: January 10, 2013
Random luteinizing hormone often remains pubertal in children treated with the histrelin implant for central precocious puberty.
Journal: The Journal of pediatrics
Published: June 01, 2012
Showing 1-6 of 6
Last Updated: 09/26/2026